M-A | Eficácia e segurança associadas a inibidores do checkpoint imunológico no carcinoma hepatocelular irressecável.
8 Dez, 2021 | 12:58h
Comentário no Twitter
This meta-analysis of RCTs shows immune checkpoint inhibitors are associated with demonstrated the superior efficacy and safety of versus standard systemic therapies in patients with unresectable hepatocellular carcinoma. https://t.co/fJdFng69qH
— JAMA Network Open (@JAMANetworkOpen) December 6, 2021